Phase 3 ADHD trials recruiting now

All ADHD trials, every phase

Other phases for ADHD

Phase 3 ADHD trials

• A Long-term Trial of EB-1020 in Adult Patients With ADHD
  NCT06926829 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• A Long-term Trial of EB-1020 in Pediatric Patients With ADHD
  NCT07087327 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 1 location
• A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
  NCT07759154 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 16 locations
• A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD
  NCT07086313 · Phase: Phase 2, Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 1 location
• Benefits of ADHD Treatment in Detained People
  NCT05842330 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Clinical Efficacy and Long Term Effects of Transcranial Direct Current Stimulation (tDCS) in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
  NCT04704687 · Phase: Phase 3 · Ages: 7 Years to 14 Years · Sex: All (male and female) · 1 location
• EEG-MRI Imaging of Methylphenidate Effects in Adult ADHD and Attentional Symptoms in Mood Disorders
  NCT05832489 · Phase: Phase 3 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
  NCT06931080 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
  NCT07717879 · Phase: Phase 3 · Ages: 6 Years to 11 Years · Sex: All (male and female) · 23 locations
• Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
  NCT07717892 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · 24 locations
• Role of Coenzyme Q in ADHD in Children
  NCT04216186 · Phase: Phase 3 · Ages: 2 Years to 18 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.